Literature DB >> 10425497

Selective Cleavage of the HIV-1 TAR-RNA with a Peptide-Cyclen Conjugate.

.   

Abstract

Covalent linkage of the arginine-rich fragment of the Tat protein to 1,4,7,10-tetraazacyclododecane (cyclen) results in the selective cleavage of the TAR-RNA of HIV-1 (see picture; the biotin at the 5' end acts as a label for the subsequent analysis of the cleavage fragments). The cleavage occurs at room temperature and is diminished when Eu(III) ions are present-at a concentration of about 1/10 of the concentration of the peptide-cyclen conjugate. The pH dependence indicates that two ammonium ions are responsible for the cleavage reaction. The white arrows in the schematic diagram mark the cleavage sites in RNase T1, and the black arrows the sites in the peptide-cyclen conjugate.

Entities:  

Year:  1999        PMID: 10425497

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.

Authors:  Natalia G Beloglazova; Martin M Fabani; Marina A Zenkova; Elena V Bichenkova; Nikolai N Polushin; Vladimir V Sil'nikov; Kenneth T Douglas; Valentin V Vlassov
Journal:  Nucleic Acids Res       Date:  2004-07-23       Impact factor: 16.971

2.  A peptide template as an allosteric supramolecular catalyst for the cleavage of phosphate esters.

Authors:  Alessandro Scarso; Ute Scheffer; Michael Göbel; Quirinus B Broxterman; Bernard Kaptein; Fernando Formaggio; Claudio Toniolo; Paolo Scrimin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

3.  Multicomponent synthesis of artificial nucleases and their RNase and DNase activity.

Authors:  Anton V Gulevich; Lyudmila S Koroleva; Olga V Morozova; Valentina N Bakhvalova; Vladimir N Silnikov; Valentine G Nenajdenko
Journal:  Beilstein J Org Chem       Date:  2011-08-19       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.